A. Zribi, K. Al Riyami, H. S. Al Zahibi, and I. A. Burney, “Managing the Adverse Events Associated with Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer”, Sultan Qaboos Univ Med J, vol. 24, no. 2, pp. 293–297, May 2024.